openPR Logo
Press release

Rapid Growth of Transcatheter aortic valve implantation (TAVI) market | Top Key Companies - Abbott Laboratories, Boston Scientific Corporation (Symetis SA), Bracco S.p.A. (HLT, Inc.), Edwards Lifesciences Corporation, JenaValve Technology, Inc., JC Medica

10-08-2018 11:39 AM CET | Health & Medicine

Press release from: Allied Market Research

Transcatheter aortic valve implantation (TAVI),

Transcatheter aortic valve implantation (TAVI),

Transcatheter aortic valve implantation (TAVI) market is projected to extent $8,138 million by 2025, rising at a CAGR of 13.8% from 2018 to 2025. The volume market was valued at 107,011 units in 2017 and is expected to reach 337,778 units by 2025, growing at a CAGR of 14.8% from 2018 to 2025.

Transcatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. These high-risk patients refer to the patient population that are inoperable and cannot undergo surgical aortic valve replacement (SAVR) procedure. Older population (above 75 years of age) falls under the high-risk category, as the open-heart procedure is too risky for them. TAVR involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise due to the increase in prevalence of aortic stenosis.

Get Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/1675

Key players have adopted product approval as their key strategy to enhance their product offerings by expanding the usage of transcatheter aortic valves for new indications, such as intermediate risk aortic stenosis patients.

The key players profiled in this report include

• Abbott Laboratories, Boston Scientific Corporation (Symetis SA)
• Bracco S.p.A. (HLT, Inc.)
• Edwards Lifesciences Corporation
• JenaValve Technology, Inc.
• JC Medical, Inc.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• NVT AG
• Venus Medtech, Inc.

In addition, increase in adoption rate of transcatheter aortic implantation along with new device approvals and improvement of healthcare infrastructure in developing countries are other factors that fuel the market growth. However, high cost of transcatheter aortic valve and its implantation procedures, along with lack of reimbursement and stringent approvals for these devices, hamper the growth of the TAVI market.

Transcatheter aortic valve implantation (TAVI) market segmented based on the approach used for implantation. Mainly, three types of approaches are used to implant the transcatheter aortic valve in patients-transfemoral, transapical, and transaortic implantation. Transfemoral implantation was the highest revenue-generating segment in the global market (in terms of value and volume) in 2017, as it does not require a chest incision. Furthermore, transaortic segment is projected to grow at the highest CAGR of 19.1% (in terms of value) and 20.1% (in terms of volume) by 2025, due to positive outcomes of several clinical trials.

Make Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1675

Key Findings of the Transcatheter Aortic Valve Implantation (TAVI) Market:
• In 2017, transfemoral implantation generated the highest revenue, and is projected to grow at a CAGR of 13.2% (in terms of value) during the forecast period.
• Both in terms of value and volume, the Europe TAVI market is expected to maintain its leading position during the forecast period.
• Asia-Pacific is expected to be the fastest growing region, and is expected to grow with a CAGR of 18.6% (in terms of value) from 2018 to 2025.
• Germany was the leading country whereas the UK is projected to be the fastest growing country in the Europe TAVI market.
• India is the fastest growing country in the Asia-Pacific TAVI market and is expected to grow at a CAGR of 29.8% (in terms of revenue) from 2018 to 2025.

Europe accounted for a major share in the global TAVI market (in terms of value and volume) in 2017, and is expected to maintain this trend. This is attributed to the rise in prevalence of severe aortic stenosis cases coupled with the increase in population of inoperable patients, and high adoption rate of advanced transcatheter aortic valves. However, Asia-Pacific is estimated to grow at a high CAGR (in terms of value and volume) throughout the analysis period, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of aortic stenosis and increase in awareness about TAVI procedures among physicians.

Access the latest trends and insights: https://www.alliedmarketresearch.com/press-release/tavi-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rapid Growth of Transcatheter aortic valve implantation (TAVI) market | Top Key Companies - Abbott Laboratories, Boston Scientific Corporation (Symetis SA), Bracco S.p.A. (HLT, Inc.), Edwards Lifesciences Corporation, JenaValve Technology, Inc., JC Medica here

News-ID: 1286592 • Views: 225

More Releases from Allied Market Research

Europe Insecticides Market reach $23.36 billion by 2026, growing at a CAGR of 5. …
According to the report, the Europe insecticides market for waste management accounted for $14.73 billion in 2018 and is anticipated to reach $23.36 billion by 2026, growing at a CAGR of 5.8% from 2019 to 2026. Generation of waste in huge amount and upsurge in number of insects drive the growth in the market. However, storage and handling of insecticides restrain the market growth. On the other hand, stringent regulations for
Trauma Devices Market Is Projected To Grow Exponentially By 2022 | major key pla …
Trauma devices are one of the various clinical procedures used for the treatment of trauma based upon the severity of injury. Trauma refers to any kind of physical injury such as fractures, dislocations, sprains & strains and burns caused by any external source. According to Center for Disease Control and Prevention, Trauma is an injury or wound to a living individual caused by due to violence or external force. These
3D Medical Imaging Market Size anticipated to witness significant growth by 2026 …
3D imaging is a revolutionary optical imaging technology that provides an enriched images on 2D platforms. This technology has the ability to offer enhanced imaging solutions in various sectors, from healthcare to entertainment to architecture modelling. Improved imaging and better viewing experience are the main attributes for its increasing demand. Moreover, the emergence of this imaging technique has allowed medical professionals to generate an in-depth image of suspect for better
Near Infrared Imaging Market Trends and Industry Analysis,Growth Prospect, durin …
Near infrared imaging is a non-invasive imaging technique that uses non-ionizing rays which helps in the detection of amount of hemoglobin present in brain and body tissues and muscles. The development of near infrared imaging has allowed the clinicians to detect brain injuries and other brain related disorders. Along with this, near infrared imaging is also being applied to diagnose breast cancer, alzheimer’s disease, depression and schizophrenia. Moreover this technique

All 5 Releases


More Releases for TAVI

Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size, Sha …
The global transcatheter aortic valve replacement (TAVR) market was valued at $3.12Billion and global transcatheter aortic valve implantation (TAVI) procedures market was valued at $7.64 Billion in 2017 and the combined market is forecast to grow at a modest25.3 % CAGR between 2018 and 2025, culminating in 2025 global sales of $XX.64 Billion. Transcatheter aortic valve replacement (TAVR) is a type of surgery in which a new valve replaced without
Cerebral Embolic Protection Devices for TAVI Market Size, Share, Forecast and In …
Transcatheter aortic valve implantation (TAVI) is the primary therapeutic option for severe aortic stenosis that are inoperable or have high surgical risk. Diffusion-weighted MRI studies demonstrates that after TAVI some silent embolic cerebral infarcts are present that lead to consecutive mental deterioration. Embolic protection devices are used to provide a mechanical barrier against the debris that cause embolization in the brain during TAVI. These devices have reduced the risk of
Transcatheter Heart Valve Replacement (TAVI) Market: Drivers, Restraint & Future …
A heart valve is present in arteries and veins and facilitates blood flow only in one direction through the heart. The four major valves in the heart are two atrioventricular valves known as bicuspid valve and tricuspid valve and two semilunar valves known as aortic valve and pulmonary valve. A heart valve separates the atria, ventricles and blood vessels from each other. A heart valve is pushed open to allow
Transcatheter aortic valve implantation (TAVI) Market - Growing Huge Business Op …
The research report intends to provide factors influencing the Transcatheter aortic valve implantation Market and gain all possible information with respect to the industry. The analysis of reports gives a satisfactory result. Transcatheter aortic valve implantation (TAVI) market revenue was valued at $2,761 million in 2017 and is expected to reach $8,138 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The volume market was valued at
Transcatheter Heart Valve Replacement (TAVI) Market : Potential and Niche Segmen …
A heart valve is present in arteries and veins and facilitates blood flow only in one direction through the heart. The four major valves in the heart are two atrioventricular valves known as bicuspid valve and tricuspid valve and two semilunar valves known as aortic valve and pulmonary valve. A heart valve separates the atria, ventricles and blood vessels from each other. A heart valve is pushed open to allow
Transcatheter Aortic Valve Implantation (TAVI) Market - Global Industry Insights …
Transcatheter aortic valve implantation (TAVI), also referred as transcatheter aortic valve replacement, or percutaneous valve replacement is a minimally invasive procedure that repairs the functionality of the old and damaged valve. The aortic valve allows the blood flow from the ventricle to the rest of the body. A malfunction in the opening and closing of this valve leads to aortic stenosis. The patients suffering from aortic stenosis suffer from extra